Evidence map›Paper›PMID 30548802›Full record

ArticleMacromolecular bioscience2019

Fabrication of Kidney Proximal Tubule Grafts Using Biofunctionalized Electrospun Polymer Scaffolds.

Katja Jansen, Miguel Castilho, Sanne Aarts, Michael M Kaminski, Soeren S Lienkamp, Roman Pichler, Jos Malda, Tina Vermonden, Jitske Jansen, Rosalinde Masereeuw

Abstract read
In one paragraph

Article in Macromolecular bioscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katja JansenDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Miguel CastilhoDepartment of Orthopaedics, University Medical Center Utrecht, Utrecht University, P.O. Box 85500,, 3508, GA Utrecht, The Netherlands.ORCID 0000-0002-4269-5889
Sanne AartsDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Michael M KaminskiUniversity Medical Center Freiburg, Zentrale Klinische Forschung, Breisacher Straße 66,, 79106, Freiburg im Breisgau, Germany.
Soeren S LienkampUniversity Medical Center Freiburg, Zentrale Klinische Forschung, Breisacher Straße 66,, 79106, Freiburg im Breisgau, Germany.ORCID 0000-0003-2963-6865
Roman PichlerUniversity Medical Center Freiburg, Zentrale Klinische Forschung, Breisacher Straße 66,, 79106, Freiburg im Breisgau, Germany.
Jos MaldaDepartment of Orthopaedics, University Medical Center Utrecht, Utrecht University, P.O. Box 85500,, 3508, GA Utrecht, The Netherlands.ORCID 0000-0002-9241-7676
Tina VermondenDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.ORCID 0000-0002-6047-5900
Jitske JansenDepartment of Pathology and Pediatric Nephrology, RIMLS, RIHS, Radboud University Medical Center, P.O. Box 9101, 6500, HB Nijmegen, The Netherlands.
Rosalinde MasereeuwDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.ORCID 0000-0002-1560-1074

Funding

European Research Council 647426FP7 Ideas: European Research Council 647426Nederlandse Organisatie voor Wetenschappelijk Onderzoek 022.006.003University Medical Center Utrecht-Technical University Eindhoven
6 · The paper itself

Abstract

The increasing prevalence of end-stage renal disease and persistent shortage of donor organs call for alternative therapies for kidney patients. Dialysis remains an inferior treatment as clearance of large and protein-bound waste products depends on active tubular secretion. Biofabricated tissues could make a valuable contribution, but kidneys are highly intricate and multifunctional organs. Depending on the therapeutic objective, suitable cell sources and scaffolds must be selected. This study provides a proof-of-concept for stand-alone kidney tubule grafts with suitable mechanical properties for future implantation purposes. Porous tubular nanofiber scaffolds are fabricated by electrospinning 12%, 16%, and 20% poly-ε-caprolactone (PCL) v/w (chloroform and dimethylformamide, 1:3) around 0.7 mm needle templates. The resulting scaffolds consist of 92%, 69%, and 54% nanofibers compared to microfibers, respectively. After biofunctionalization with L-3,4-dihydroxyphenylalanine and collagen IV, 10 × 10

Indexed as

Tissue ScaffoldsBiocompatible MaterialsCaproatesCell ProliferationCells, CulturedEpithelial CellsHumansKidney Failure, ChronicKidney Tubules, ProximalLactonesPolymersTissue EngineeringTransplantsBiocompatible MaterialsCaproatescaprolactoneLactonesPolymerspolycaprolactoneregenerative medicinerenal replacement therapyrenal transporttissue engineering

Identifiers

PMID30548802
PMCPMC7116029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.